Class II · Moderate riskTerminated Initiated May 4, 2016 (10 years ago)
OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose Vial, Rx…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Failed Impuities/Degradation Specifications
What was recalled
OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose Vial, Rx only, Manufactured by Fresenius Kabi USA, LLC, Schaumburg, IL 60173, NDC 63323-365-04
Recalling firm
Fresenius Kabi USA, LLC
NDC code
63323-365-04
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0867-2016
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Teva Pharmaceuticals USA, IncNDC 0480-9262-08D-0406-2026
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Teva Pharmaceuticals USA, IncNDC 0480-9259-08D-0405-2026
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Teva Pharmaceuticals USA, IncNDC 0480-9257-08D-0404-2026